Visalytics
Visalytics
approved EB-2 (NIW)

Scientist

Biochemistry · Sri Lanka · 2024-02-08

Processing Time
3 days
Decision Date
2024-02-08
Location
Ohio
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on developing new methodologies for engineering and characterizing novel proteins and antibodies. This work aims to further biomedical studies, the biotechnology industry, and healthcare by providing foundations for innovations in therapeutic treatments.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research provides a foundation for innovations in biotechnology and biomedicine that add significant value to the global economy and public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of published research, citations, and receipt of NIH funding demonstrates readiness to advance the field of biochemistry.

3 Balance of Factors Met

The innovative protein engineering developments are crucial for U.S. leadership in the sector, justifying a waiver of the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 3 peer-reviewed journal articles, 1 conference abstract, and 1 preprint which garnered 17 citations. The case demonstrated substantial merit through NIH funding support and the potential for significant economic and public health impact, satisfying the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 292 days 2025-02-27
The petitioner proposes to develop engineering approaches for the production of therapeutic antibodies and novel antibody-like proteins. Her work focuses on improving clinical outcomes in oncology, immunology, and anti-infection applications by creating tools to overcome therapeutic resistance and metastasis. Additionally, she aims to enhance production efficiency to ensure broader accessibility of life-saving treatments.
View Case

Postdoctoral Researcher

Research and Development · China

WeGreened EB-2 (NIW) approved
California 30 days 2023-02-09
The petitioner proposes to continue her research on advancing novel protein characterization approaches for discovering and engineering antibodies. This work focuses on developing a protein engineering strategy to produce antibodies with improved dose potency and creating new therapeutics that target difficult diseases.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Washington 369 days 2025-02-05
The petitioner proposes to advance computational algorithms and experimental screening techniques to streamline the creation of modular, low-cost, and efficient protein therapeutics. This work focuses on improving the stability and production of drugs like antibodies and insulins to eliminate cold-chain transportation barriers and reduce healthcare costs.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 5 days 2024-03-20
The petitioner proposes to continue her research on developing biomanufacturing processes to produce therapeutic moieties such as biologics, small molecules, and cell and gene therapies. Her work focuses on achieving optimal-quality treatments for diseases including cancer, inflammation, and rare diseases while expanding the availability of top-tier therapies through biomanufacturing innovations.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Sri Lanka

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-02-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 3 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Sri Lanka All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist